0362U prior authorization | Anthem Blue Cross and Blue Shield New Hampshire

0362U, Oncology (papillary thyroid cancer), gene- expression profiling via targeted hybrid capture-enrichment RNA sequencing of 82 content genes and 10 housekeeping genes, fine needle aspirate or formalin- fixed paraffin-embedded (FFPE) tissue, algorithm reported as one of three molecular subtypes, is on the Anthem Blue Cross and Blue Shield New Hampshire prior authorization list. Not a coverage or referral decision.

Code

0362U

Description

Oncology (papillary thyroid cancer), gene- expression profiling via targeted hybrid capture-enrichment RNA sequencing of 82 content genes and 10 housekeeping genes, fine needle aspirate or formalin- fixed paraffin-embedded (FFPE) tissue, algorithm reported as one of three molecular subtypes

Source

New Hampshire Precertification List, Pg 47 Original policy

Anthem Blue Cross and Blue Shield New Hampshire prior authorization